Open access peer-reviewed chapter

Circulating Advanced Oxidation Protein Products, Nε-(Carboxymethyl) Lysine and Pro-Inflammatory Cytokines in Patients with Liver Cirrhosis: Correlations with Clinical Parameters

By Jolanta Zuwala-Jagiello, Eugenia Murawska-Cialowicz and Monika Pazgan-Simon

Submitted: April 12th 2011Reviewed: November 24th 2011Published: April 25th 2012

DOI: 10.5772/32553

Downloaded: 1325

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Jolanta Zuwala-Jagiello, Eugenia Murawska-Cialowicz and Monika Pazgan-Simon (April 25th 2012). Circulating Advanced Oxidation Protein Products, Nε-(Carboxymethyl) Lysine and Pro-Inflammatory Cytokines in Patients with Liver Cirrhosis: Correlations with Clinical Parameters, Oxidative Stress and Diseases, Volodymyr I. Lushchak and Dmytro V. Gospodaryov, IntechOpen, DOI: 10.5772/32553. Available from:

chapter statistics

1325total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Oxidative Stress in Parkinson's Disease; Parallels Between Current Animal Models, Human Studies and Cells

By Anwar Norazit, George Mellick and Adrian C. B. Meedeniya

Related Book

First chapter

Introductory Chapter

By Volodymyr I. Lushchak and Halyna M. Semchyshyn

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us